Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Phone coaching gets seniors moving after lung surgery

NCT ID NCT06196008

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether telephone-based physical activity coaching can improve physical function in adults aged 65 and older who are having lung cancer surgery, as well as their family caregivers. Participants will either receive regular coaching calls or track their own activity. The goal is to see if remote coaching helps maintain strength and mobility during recovery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 382 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2023

Expected to finish

May 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * PATIENT: Documented informed consent of the participant and/or legally authorized representative * PATIENT: Agreement to allow the use of preoperative chest CT scan for exploratory analysis, if available * PATIENT: Agreement to wear pedometer during study duration * If unwilling, exceptions may be granted with study primary investigator (PI) approval * PATIENT: Age \>= 65 years * PATIENT: Ability to read and understand English or Spanish and willingness to complete participant-reported outcomes and assessments * PATIENT: Diagnosis of lung cancer or presumed lung cancer (as determined by surgeons) in patient * PATIENT: Scheduled to undergo lung surgery for lung cancer or suspected lung cancer with curative intent (neoadjuvant therapy allowed) * PATIENT: Adults lacking capacity to consent in the opinion of the attending surgeon will not be enrolled * FCG: Documented informed consent of the participant and/or legally authorized representative * FCG: Age \>= 18 * FCG: Ability to read and understand English or Spanish and willingness to complete participant-reported outcomes and assessments * FCG: Adults lacking capacity to consent in the opinion of the attending surgeon will not be enrolled Exclusion Criteria: * PATIENT: Lung surgery is scheduled in less than 14 calendar days from the time of registration * PATIENT: Prospective participants who, in the opinion of the investigator, may not be able to comply with all study procedures (including exercise program and compliance issues related to feasibility/logistics) * FCG: Prospective participants who, in the opinion of the investigator, may not be able to comply with all study procedures (including exercise program and compliance issues related to feasibility/logistics)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Lung cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    16 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Baptist Clinical Research Institute

    RECRUITING

    Memphis, Tennessee, 38120, United States

  • City of Hope Medical Center

    RECRUITING

    Duarte, California, 91010, United States

  • City of Hope at Georgia - Atlanta

    RECRUITING

    Newnan, Georgia, 30265, United States

  • City of Hope at Irvine Lennar

    RECRUITING

    Irvine, California, 92618, United States

  • City of Hope at Upland

    RECRUITING

    Upland, California, 91786, United States

  • Duke University

    RECRUITING

    Durham, North Carolina, 27710, United States

  • Lahey Hospital & Medical Center

    RECRUITING

    Burlington, Massachusetts, 01805, United States

  • MD Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030, United States

  • Massachusetts General Hospital (MGH) / Harvard

    RECRUITING

    Boston, Massachusetts, 02114, United States

  • Moffitt Cancer Center

    RECRUITING

    Tampa, Florida, 33612, United States

  • Northwestern University

    RECRUITING

    Evanston, Illinois, 60208, United States

  • Ohio State University

    RECRUITING

    Columbus, Ohio, 43210, United States

  • Standard University

    RECRUITING

    Stanford, California, 94305, United States

  • University of California

    RECRUITING

    Davis, California, 95616, United States

  • University of Mississippi Medical Center

    RECRUITING

    Jackson, Mississippi, 39216, United States

  • Yale New Haven Medical Center

    RECRUITING

    New Haven, Connecticut, 06510, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.